Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2<sup>+</sup> glioma patients

JIN Mingyue; JIN Mingyue; JIN Mingyue; KOMOHARA Yoshihiro; SHICHIJO Shigeki; SHICHIJO Shigeki; YAMANAKA Ryuya; YAMANAKA Ryuya; NIKAWA Junichi; ITOH Kyogo; ITOH Kyogo; ITOH Kyogo; YAMADA Akira; YAMADA Akira

Art

J-GLOBAL ID：200902231391156550 Reference number：08A0871902

Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2⁺ glioma patients

ヒト白血球抗原A2⁺神経膠腫患者における神経膠腫反応性細胞傷害性T細胞を誘発する能力を持ったペプチド由来のエリスロポイエチン産生肝細胞B6変異株

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=08A0871902&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0871902&from=J-GLOBAL&jstjournalNo=W1423A") }}

Author (14)： , , , , , , , , , , , , ,
Material：
Volume： 99 Issue： 8 Page： 1656-1662 Publication year： Aug. 2008
JST Material Number： W1423A ISSN： 1347-9032 Document type： Article
Article type：原著論文 Country of issue： Australia (AUS) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0871902&from=J-GLOBAL&jstjournalNo=W1423A") }}

Chemistry,biochemistry and pathology of tumors(=neoplasms) , Tumors(=neoplasms)of nervous system

Reference (22)：

STUPP, R. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005, 352, 987-996
YAMANAKA, R. Novel immunotherapeutic approaches to glioma. Curr Opin Mol Ther. 2006, 8, 46-51
DRANOFF, G. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA. 1993, 90, 3539-3543
ROSENBERG, SA. Cancer immunotherapy : moving beyond current vaccines. Nat Med. 2004, 10, 909-915
ITOH, K. Personalized peptide vaccines : a new therapeutic modality for cancer. Cancer Sci. 2006, 97, 970-976

ｍore...

, , , , , , , , , ,

Return to Previous Page

Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients

Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2⁺ glioma patients